Patents by Inventor Arnold Oronsky

Arnold Oronsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions utilizing RRx-001 combination therapy for radioprotection
    Patent number: 11510901
    Abstract: Provided herein are therapeutic methods, kits, and pharmaceutical compositions for protecting a subject from radiation using a therapeutic agent selected from the group consisting of RRx-OO1 and a pharmaceutically acceptable salt thereof. One exemplary therapeutic method involves administering RRx-OO1 to the subject prior to the subject being exposed to the radiation, in order to protect the subject against radiation, such as ionizing radiation containing ?-rays, ?-rays, ?-rays, neutron radiation, or a combination thereof.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: November 29, 2022
    Assignee: EpicentRx, Inc.
    Inventors: Bryan T. Oronsky, Arnold Oronsky, Tony R. Reid
  • Tumor activated prodrug compounds and methods of making and using the same
    Publication number: 20040014652
    Abstract: The invention is directed to novel prodrug compounds, compositions comprising the prodrug compounds, methods of making the prodrug compounds and methods of using the prodrug compounds. The prodrug compounds comprise a biologically active entity linked to a masking moiety via a linking moiety. The prodrug compounds are selectively activated at or near target cells and display lower toxicity and possibly a longer in vivo or serum half-life than the corresponding naked biologically active entity.
    Type: Application
    Filed: June 16, 2003
    Publication date: January 22, 2004
    Inventors: Andre Trouet, Vincent Dubois, Arnold Oronsky